Renal outcomes in the ONTARGET study

The Lancet

Volumn 372, Issue 9655, 2008, Pages 2019-2020

  Nonoguchi, Hiroshi ^a   Nanami, Masayoshi ^a   Hasuike, Yukiko ^a   Kuragano, Takahiro ^a   Nakanishi, Takeshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TELMISARTAN;

ALBUMINURIA; ANTIHYPERTENSIVE ACTIVITY; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DISEASE; LETTER; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG COMBINATION; NOTE; PATIENT SELECTION; ACUTE KIDNEY FAILURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR DISEASE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; PATIENT SELECTION; PROTEINURIA; KIDNEY FAILURE, ACUTE; RENIN-ANGIOTENSIN SYSTEM; VASCULAR DISEASES;

EID: 57349177991     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61861-9     Document Type: Letter

References (5)

1. Mann J.F., Schmieder R.E., McQueen M., et al., on behalf of the ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372 (2008) 547-553
2. Klahr S., Levey A.S., Beck G.J., et al., for the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330 (1994) 877-884
3. Mann J.F., Gerstein H.C., Yi Q.L., et al., on behalf of the HOPE Investigators. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis 42 (2003) 936-942
4. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857-1863
5. Catapano F., Chiodini P., Nicola L.D., et al. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. Am J Kidney Dis 52 (2008) 475-485